Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice.
about
CD36: implications in cardiovascular diseaseAnimal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesImaging of small animal peripheral artery disease models: recent advancements and translational potentialRecovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.Chinese consensus statement on the evaluation and intervention of collateral circulation for ischemic strokeProtease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model.Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndromeThe biphasic effects of oxidized-low density lipoprotein on the vasculogenic function of endothelial progenitor cells.Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury.Endothelial glycocalyx dimensions are reduced in growing collateral arteries and modulate leucocyte adhesion in arteriogenesis.Vascular development during distraction osteogenesis proceeds by sequential intramuscular arteriogenesis followed by intraosteal angiogenesis.Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox.Hemodynamic determinants of perivascular collateral development in swine renal artery stenosis.NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivoArteriogenesis: basic mechanisms and therapeutic stimulation.Role of image-guided vascular intervention in therapeutic angiogenesis translational research.Exercise training and peripheral arterial disease.Insights into mechanisms behind arteriogenesis: what does the future hold?Endothelial fluid shear stress sensing in vascular health and disease.Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.Syndesome Therapeutics for Enhancing Diabetic Wound HealingImpaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
P2860
Q24678338-1AAC0446-8509-4076-8777-30352B131E1EQ26822630-24FFDFCC-AF74-4BE6-99B3-5DE1B3FF2A59Q27009178-D6CB56CF-6F17-416C-95F8-9E4A772D4351Q33553042-796505C6-D5AB-4E97-8B96-A5C3D6368A79Q34522111-68E26493-A516-4296-9B3A-18B48C31DA30Q34700750-2BE72D1A-B40B-4783-9EF5-34F342C3CA1CQ35603166-2E3CC099-5C2F-4291-BD6D-E3B302861324Q35643408-986D39E6-C82C-4DB5-A877-1EF59EDEE7B9Q35762857-C6B6886F-A7E0-43C0-951B-2F86BFF98F5EQ35893318-7AFA4E77-7D6B-4ADC-AEC8-CBDF9879C6FEQ36143963-0E6300D8-F620-4556-BEDB-BCEB2B254742Q36339217-A61528D8-0199-409B-AD48-7EBF9BE13107Q36764890-9D268830-5EFA-4024-9274-19A2B31374CAQ36893418-DFC6FF3B-ADB1-4BD5-8FFE-44E3AD6944DAQ36925987-2F43B73B-946A-45BB-BBEC-6698D339FB07Q36941842-592C1F6E-7548-443D-998F-F10373145CEAQ37157213-AF4F7EC6-4BBE-4BD0-A101-093C908578D5Q37234751-BDBA32DC-05BA-4B0A-9E98-F0E84C3AE8FDQ38630594-5B51E03E-5759-41DD-A77E-4489CC2826A3Q39248182-C7C774B8-A07F-4F9E-9439-1040C0BD91E2Q41421987-8B7ECF8C-07F3-4EC7-B1C4-B021A394655AQ42571891-83A1A975-5591-43DB-9BAE-A3B1D881B7F9Q58579298-2B99F660-D45F-4C1F-9378-0937097F4C71
P2860
Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@ast
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@en
type
label
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@ast
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@en
prefLabel
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@ast
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@en
P2093
P921
P1476
Hypercholesterolemia reduces c ...... or insulin resistance in mice.
@en
P2093
J Hajo van Bockel
Margreet de Vries
Paul H A Quax
Paul H C Eilers
Peter J Voshol
Robert E Verloop
Victor W M van Hinsbergh
Vincent van Weel
P304
P356
10.1161/01.ATV.0000219234.78165.85
P407
P577
2006-03-30T00:00:00Z